Research programme: PPAR gamma agonists - 3SBioAlternative Names: DJ-5
Latest Information Update: 08 Nov 2013
At a glance
- Originator Shanghai Institute of Materia Medica
- Developer 3SBio; Shanghai Institute of Materia Medica
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Renal failure
Most Recent Events
- 29 Oct 2013 Preclinical trials in Renal failure in China (unspecified route)